Response to selpercatinib versus prior systemic therapy in patients (pts) with RET fusion plus non-small-cell lung cancer (NSCLC).

被引：2

作者：

Drilon, Alexander E.

Gautschi, Oliver

Besse, Benjamin

Subbiah, Vivek

Tan, Daniel Shao-Weng

Park, Keunchil

De Braud, Filippo G.

Alonso, Guzman

Wolf, Juergen

Soldatenkova, Victoria

French, Pearl Plernjit

Lin, Aimee K.

Goto, Koichi

Solomon, Benjamin J.

机构：

[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

[2] Weill Cornell Med Coll, New York, NY USA

[3] Univ Bern, Luzern, Switzerland

[4] Cantonal Hosp Lucerne, Luzern, Switzerland

[5] Gustave Roussy, Dept Med, Villejuif, France

[6] Gustave Roussy, Thorac Pathol Comm, Villejuif, France

[7] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[8] Natl Canc Ctr Singapore, Singapore, Singapore

[9] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol, Seoul, South Korea

[10] Univ Milan, Fdn IRCCS, Ist Nazl Tumori, ENETS Ctr Excellence,Med Oncol Dept, Milan, Italy

[11] Univ Milan, Oncol & Hematooncol Dept, Milan, Italy

[12] Vall dHebron Univ Hosp HUVH, Vall dHebron Inst Oncol VHIO, Med Oncol, Barcelona, Spain

[13] Univ Hosp Cologne, Ctr Integrated Oncol, Dept Internal Med, Cologne, Germany

[14] Eli Lilly & Co, Indianapolis, IN 46285 USA

[15] Natl Canc Ctr Hosp East, Kashiwa, Chiba, Japan

[16] Univ Melbourne, Peter MacCallum Canc Ctr, Res Div, Melbourne, Vic, Australia

[17] Univ Melbourne, Dept Med Oncol, Melbourne, Vic, Australia

[18] Univ Melbourne, Res Div, Peter MacCallum Canc Ctr, Melbourne, Vic, Australia

[19] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期

关键词：

D O I：

10.1200/JCO.2021.39.15_suppl.9032

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

9032

引用

页数：2